Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay M Lee

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Plos One|July 21, 2012
Myeloid suppressor cell depletion augments antitumor activity in lung cancerMinu K Srivastava, Li Zhu, Marni Harris-White, et al.
Heart Rhythm|December 15, 2019
Prognostic impact of atrial rhythm and dimension in patients with structural heart disease undergoing cardiac sympathetic denervation for ventricular arrhythmiasVeronica Dusi, Julie M Sorg, Jeffrey Gornbein, et al.
American Journal of Translational Research|August 25, 2010
PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancerFelicita Baratelli, Jay M Lee, Saswati Hazra, et al.
Practical Radiation Oncology|October 4, 2015
Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesotheliomaAmar U Kishan, Robert B Cameron, Pin-Chieh Wang, et al.
JTO Clinical and Research Reports|August 11, 2025
Phase 3 Trials of Neoadjuvant, Perioperative, and Adjuvant Chemoimmunotherapy for Resectable, Early-Stage NSCLC: Comprehensive Review and Detailed AnalysisJay M Lee, Alessandro Brunelli, Amy L Cummings, et al.
Cancers|February 20, 2025
Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. <i>Cancers</i> 2024, <i>16</i>, 2492Nicolas Girard, Mariam Besada, Basia Rogula, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomasPuja Kachroo, Peter S Pak, Harpavan S Sandha, et al.
Cancers|July 13, 2024
Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-AnalysisNicolas Girard, Mariam Besada, Basia Rogula, et al.
JTO Clinical and Research Reports|July 30, 2024
Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung CancerJohn Nikitas, Jane Yanagawa, Sandra Sacks, et al.
Cellular and Molecular Life Sciences : CMLS|June 13, 2012
Development of transcriptomic biomarker signature in human saliva to detect lung cancerLei Zhang, Hua Xiao, Hui Zhou, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Plos One|July 21, 2012
Myeloid suppressor cell depletion augments antitumor activity in lung cancerMinu K Srivastava, Li Zhu, Marni Harris-White, et al.
Heart Rhythm|December 15, 2019
Prognostic impact of atrial rhythm and dimension in patients with structural heart disease undergoing cardiac sympathetic denervation for ventricular arrhythmiasVeronica Dusi, Julie M Sorg, Jeffrey Gornbein, et al.
American Journal of Translational Research|August 25, 2010
PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancerFelicita Baratelli, Jay M Lee, Saswati Hazra, et al.
Practical Radiation Oncology|October 4, 2015
Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesotheliomaAmar U Kishan, Robert B Cameron, Pin-Chieh Wang, et al.
JTO Clinical and Research Reports|August 11, 2025
Phase 3 Trials of Neoadjuvant, Perioperative, and Adjuvant Chemoimmunotherapy for Resectable, Early-Stage NSCLC: Comprehensive Review and Detailed AnalysisJay M Lee, Alessandro Brunelli, Amy L Cummings, et al.
Cancers|February 20, 2025
Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. <i>Cancers</i> 2024, <i>16</i>, 2492Nicolas Girard, Mariam Besada, Basia Rogula, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomasPuja Kachroo, Peter S Pak, Harpavan S Sandha, et al.
Cancers|July 13, 2024
Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-AnalysisNicolas Girard, Mariam Besada, Basia Rogula, et al.
JTO Clinical and Research Reports|July 30, 2024
Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung CancerJohn Nikitas, Jane Yanagawa, Sandra Sacks, et al.
Cellular and Molecular Life Sciences : CMLS|June 13, 2012
Development of transcriptomic biomarker signature in human saliva to detect lung cancerLei Zhang, Hua Xiao, Hui Zhou, et al.
Pageof 10